Literature DB >> 6177634

Augmented followed by suppressed levels of natural cell-mediated cytotoxicity in mice infected with Toxoplasma gondii.

T Kamiyama, T Hagiwara.   

Abstract

The cytotoxic activity of effector cells from mice infected with Toxoplasma gondii was tested in a 4- to 5-hr (51)Cr release assay, using RL [vertical male] 1 and YAC-1 target cells. They showed enhanced cytotoxicity with a peak on the 3rd day postinfection followed by suppression with a peak on the 12th day. The cytotoxicity seemed to be exhibited by natural killer (NK) cells because: (i) pretreatment of the effector cells with antiasialo GM(1) or antiasialo GM(2) plus complement abolished the cytotoxic activity; (ii) the altered cytotoxicity levels were also induced in nude mice; and (iii) the activity was elicited by nonadherent-nonphagocytic cells. The alteration occurred simultaneously in various lymphoid organs with a similar profile. Neither spleen nor bone marrow cells of 12-day-postinfected mice inhibited NK activity of uninfected mice. Culture fluids of the infected mouse spleen and bone marrow cells did not affect the normal mouse NK activity. The proportion of effector cells capable of binding to target cells was constant during the infection. There was no positive correlation between NK activity and serum interferon level; i.e., interferon was detected in the serum of 12-day-postinfected mice but not in that of 3-day-postinfected or uninfected mice. Passively administered interferon or polyinosinic-polycytidylic acid could not restore the suppressed NK activity of 12-day-postinfected mice. Moreover, in vitro treatment of spleen cells from 12-day-postinfected mice with interferon failed to restore the suppressed NK activity. These results suggested that after toxoplasma infection, defective sensitivity to interferon was induced in NK precursor cells, and differentiation to functionally active NK cells might be blocked.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177634      PMCID: PMC351275          DOI: 10.1128/iai.36.2.628-636.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Improved assays for a variety of interferons. 1.

Authors:  H K Oie; C E Buckler; C P Uhlendorf; D A Hill; S Baron
Journal:  Proc Soc Exp Biol Med       Date:  1972-09

2.  Toxoplasmosis of animals in Japan.

Authors:  T Hagiwara
Journal:  Int J Zoonoses       Date:  1977-12

3.  Mode of action of interferon-mediated modulation of natural killer cytotoxic activity: recruitment of pre-NK cells and enhanced kinetics of lysis.

Authors:  A Silva; B Bonavida; S Targan
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

4.  Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells.

Authors:  S Targan; F Dorey
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

5.  Introduction of "natural" killer' cells by BCG.

Authors:  S A Wolfe; D E Tracey; C S Henney
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

6.  A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells.

Authors:  M J Droller; M U Schneider; P Perlmann
Journal:  Cell Immunol       Date:  1978-08       Impact factor: 4.868

7.  Depressed antibody responses to a thymus-dependent antigen in toxoplasmosis.

Authors:  G T Strickland; P C Sayles
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

8.  A glycolipid on the surface of mouse natural killer cells.

Authors:  M Kasai; M Iwamori; Y Nagai; K Okumura; T Tada
Journal:  Eur J Immunol       Date:  1980-03       Impact factor: 5.532

9.  Human natural killer cell activity is augmented by interferon via recruitment of 'pre-NK' cells.

Authors:  E Saksela; T Timonen; K Cantell
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

10.  Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo.

Authors:  J Y Djeu; K Y Huang; R B Herberman
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

View more
  12 in total

1.  The IL-12- and IL-23-Dependent NK Cell Response Is Essential for Protective Immunity against Secondary Toxoplasma gondii Infection.

Authors:  Daria L Ivanova; Tiffany M Mundhenke; Jason P Gigley
Journal:  J Immunol       Date:  2019-10-11       Impact factor: 5.422

2.  Intestinal intraepithelial and splenic natural killer cell responses to eimerian infections in inbred chickens.

Authors:  H S Lillehoj
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

3.  Effect of Toxoplasma infection on the sensitivity of mouse thymocytes to natural killer cells.

Authors:  T Kamiyama; M Tatsumi
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

4.  Absence of a role for natural killer cells in the control of acute infection by Toxoplasma gondii oocysts.

Authors:  H P Hughes; L H Kasper; J Little; J P Dubey
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

5.  Toxoplasma-induced activities of peritoneal and spleen natural killer cells from beige mice against thymocytes and YAC-1 lymphoma targets.

Authors:  T Kamiyama
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

6.  Induction of antigen-specific human cytotoxic T cells by Toxoplasma gondii.

Authors:  I A Khan; K A Smith; L H Kasper
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  Enhanced natural killer cell activity in experimental murine encephalitozoonosis.

Authors:  J Y Niederkorn; J K Brieland; E Mayhew
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

8.  Leishmaniasis in beige mice.

Authors:  C E Kirkpatrick; J P Farrell
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Gamma interferon-dependent temporary resistance to acute Toxoplasma gondii infection independent of CD4+ or CD8+ lymphocytes.

Authors:  L L Johnson; F P VanderVegt; E A Havell
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  Biochemical and immunological characterization of Toxoplasma gondii macrophage migration inhibitory factor.

Authors:  Caroline Sommerville; Julia M Richardson; Roderick A M Williams; Jeremy C Mottram; Craig W Roberts; James Alexander; Fiona L Henriquez
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.